Who Owns CHRS?

Coherus Oncology, Inc. — Institutional Ownership & 13F Holdings

$1.82

+0.08 (+4.60%)

Market Cap

$215.5M

Shares Outstanding

117,144,444

Institutional Holders

116

Total Inst. Value

$55.8M

% of Float Held

57.2%

QoQ Holder Change

+6

Institutional data as of Q1 2025

New Positions

17

Closed Positions

18

Increased

40

Decreased

30

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1VANGUARD GROUP INC$9.0M11,151,905
2BlackRock, Inc.$8.9M10,978,359
3NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO$7.9M9,850
4Rubric Capital Management LP$4.2M5,258,754
5TANG CAPITAL MANAGEMENT LLC$4.1M5,097,362
6Kohlberg Kravis Roberts & Co. L.P.$2.4M3,036,076
7GEODE CAPITAL MANAGEMENT, LLC$2.1M2,655,500
8STATE STREET CORP$1.8M2,226,851
9CM Management, LLC$1.7M2,147,500
10C WorldWide Group Holding A/S$1.6M1,928,464

Biggest Buyers & Sellers This Quarter

Famous Fund Managers

Related Stocks

Frequently Asked Questions

How many institutional investors hold CHRS?

As of Q1 2025, 116 institutional investors report holding CHRS (Coherus Oncology, Inc.) in their 13F filings.

What percentage of Coherus Oncology, Inc. is owned by institutions?

Institutional investors hold approximately 57.2% of Coherus Oncology, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most CHRS?

The largest institutional holder of CHRS is VANGUARD GROUP INC with $9.0M in shares.

Are institutions buying or selling CHRS?

This quarter, 17 institutions opened new positions in CHRS and 18 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.